Jeffrey M.  Dayno net worth and biography

Jeffrey Dayno Biography and Net Worth

Jeffrey M. Dayno, M.D., is Chief Medical Officer for Harmony Biosciences. A nationally recognized expert in neuroscience, Dr. Dayno is currently responsible for managing research, development and medical and regulatory affairs for Harmony Biosciences.

He is a neurologist with 10 years experience in clinical/academic medicine followed by over 20 years experience in leadership roles at Merck & Co., Cephalon, and ViroPharma, building and leading clinical, regulatory and medical affairs teams toward multiple NDA approvals and medical support of successful product launches.

Dr. Dayno has served as Principal Investigator on numerous clinical trials and published and lectured extensively on various topics in the field of Neurology, with a focus on stroke, sleep disorders, pain and migraine. He has also served as a peer reviewer for several scientific neurology journals.

Dr. Dayno earned his medical degree from Temple University School of Medicine, did his residency training in Neurology at Temple University Hospital, and completed a fellowship in Stroke and Cerebrovascular Disorders in the Department of Neurology at Henry Ford Hospital.

What is Jeffrey M. Dayno's net worth?

The estimated net worth of Jeffrey M. Dayno is at least $624,307.36 as of March 31st, 2017. Dr. Dayno owns 18,212 shares of Harmony Biosciences stock worth more than $624,307 as of December 21st. This net worth approximation does not reflect any other investments that Dr. Dayno may own. Additionally, Dr. Dayno receives an annual salary of $1,260,000.00 as Insider at Harmony Biosciences. Learn More about Jeffrey M. Dayno's net worth.

How old is Jeffrey M. Dayno?

Dr. Dayno is currently 67 years old. There are 2 older executives and no younger executives at Harmony Biosciences. Learn More on Jeffrey M. Dayno's age.

What is Jeffrey M. Dayno's salary?

As the Insider of Harmony Biosciences Holdings, Inc., Dr. Dayno earns $1,260,000.00 per year. Learn More on Jeffrey M. Dayno's salary.

How do I contact Jeffrey M. Dayno?

The corporate mailing address for Dr. Dayno and other Harmony Biosciences executives is 630 W GERMANTOWN PIKE SUITE 215, PLYMOUTH MEETING PA, 19462. Harmony Biosciences can also be reached via phone at 484-539-9800 and via email at [email protected]. Learn More on Jeffrey M. Dayno's contact information.

Has Jeffrey M. Dayno been buying or selling shares of Harmony Biosciences?

Jeffrey M. Dayno has not been actively trading shares of Harmony Biosciences in the last ninety days. Learn More on Jeffrey M. Dayno's trading history.

Who are Harmony Biosciences' active insiders?

Harmony Biosciences' insider roster includes Jeffrey Dayno (Insider), Jeffrey Dierks (Insider), John Jacobs (CEO), and Andreas Wicki (Director). Learn More on Harmony Biosciences' active insiders.

Are insiders buying or selling shares of Harmony Biosciences?

In the last year, insiders at the sold shares 4 times. They sold a total of 33,869 shares worth more than $1,267,489.12. The most recent insider tranaction occured on October, 29th when insider Jeffrey Dierks sold 21,496 shares worth more than $869,943.12. Insiders at Harmony Biosciences own 30.8% of the company. Learn More about insider trades at Harmony Biosciences.

Information on this page was last updated on 10/29/2024.

Jeffrey M. Dayno Insider Trading History at Harmony Biosciences

See Full Table

Jeffrey M. Dayno Buying and Selling Activity at Harmony Biosciences

This chart shows Jeffrey M. Dayno's buying and selling at Harmony Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Harmony Biosciences Company Overview

Harmony Biosciences logo
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Read More

Today's Range

Now: $34.28
Low: $33.48
High: $34.97

50 Day Range

MA: $34.24
Low: $31.86
High: $41.49

2 Week Range

Now: $34.28
Low: $28.14
High: $41.61

Volume

2,976,575 shs

Average Volume

487,868 shs

Market Capitalization

$1.96 billion

P/E Ratio

16.25

Dividend Yield

N/A

Beta

0.79